Category: Private Citizen — Corporate Director Role: Independent Director, BlackRock Inc. (BLK) Board Tenure: 2021 – present Committee Memberships: Nominating & Governance Committee Profile Type: Board Member Accountability — Anchor B (Documented Organizational Leadership)

Basis for Inclusion: Kristin C. Peck holds a documented governance role as an independent director and Nominating & Governance Committee member at BlackRock Inc., which made documented political donations to Trump-aligned entities. This profile documents the factual governance relationship, not the subject’s personal political views.

Subject Classification: Private Citizen / Corporate Director. Board membership is a matter of public record (SEC filings, proxy statements). This profile documents only the governance role and its connection to documented corporate political activity.

Biographical Overview

Kristin C. Peck has been CEO of Zoetis Inc. since 2020. Zoetis is the world’s leading animal health company — a Pfizer spinoff that was taken public in 2013 — with over $8 billion in annual revenue from livestock and companion animal pharmaceuticals, vaccines, and diagnostics. Before becoming Zoetis CEO, she served as its EVP and Group President and held senior strategy and business development roles at Pfizer.

Peck joined the BlackRock board in 2021. Her background in pharmaceutical and animal health company leadership, regulatory affairs across multiple global markets, and experience at Pfizer’s corporate strategy level gives her relevant expertise on risk management and governance practices in complex regulated industries.

Board Role and Governance Authority

• Company: BlackRock Inc. (NYSE: BLK)
• Board tenure: 2021 – present
• Committee assignments: Nominating & Governance Committee
• Day job: CEO, Zoetis Inc. (NYSE: ZTS)

Parent Corporate Donor Profile

This profile is a governance-accountability companion to the BlackRock — Corporate Donor Profile.

Factual correction requests: If you believe information in this profile is incorrect, please contact factcheck@patriot.university with your name (optional), the specific claim, and any supporting documentation. We review all submissions and correct verified errors promptly.

Sources

• BlackRock Inc. DEF 14A Proxy Statement, filed April 4, 2025; SEC EDGAR (CIK 2012383)